Ralph Weissleder's Lab
The Lab has a unique operation. We have always focused on selecting ideas that would have the greatest positive impact for humanity (for some current projects see here). Our primary focus is to:
- Obtain a deeper understanding of human biology in health and disease
- Translate new biological understanding into clinically useful diagnostics
- Identify new therapeutic approaches and drug targets
- Quantitative in vivo measurements
- Systems-wide global measurements
- Dynamic, serial measurements
- An fine-grained understanding of in vivo function
Evolution of macromolecular complexity in drug delivery systems
Nat Rev Chem. 2017;1:0063
Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior
Adv Drug Deliv Rev. 2017;113:61-86
Integrated Magneto-Chemical Sensor For On-Site Food Allergen Detection.
ACS Nano. 2017;:ePub - PMID: 28792732
Novel nanosensing technologies for exosome detection and profiling.
Lab Chip. 2017;17(17):2892-2898 - PMID: 28745363
2017-08-10: CSB has been named as one of the NCI Innovative Research in Cancer Nanotechnology (IRCNs). The IRCNs engage in directed, product-focused research that aims to translate cutting-edge science and technology into the next generation of diagnostic and therapeutic tools. These platforms serve as the core technologies for a wide array of specific applications that will ultimately benefit cancer patients.
2017-07-24: Jouha Min, PhD (Weissleder Lab) received the Masoumeh Ghaderi Prize for Best Sound-Bite Presentation (1st Place) at the 5th Annual Workshop on Micro- and Nanotechnologies for Medicine: Emerging Frontiers and Applications.
2017-05-19: Sean Arlauckas of the Weissleder lab won the Tayyaba Hasan, PhD ORCD Poster of Prestige Award for top abstract at this year’s MGH Research Fellow Poster Celebration. The prize recognizes outstanding contributions to the MGH research enterprise.